![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 38/26 | |
C07K 14/605 |
(11) | Patento numeris | 3458084 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17725143.6 |
Europos patento paraiškos padavimo data | 2017-05-15 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-03-27 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-01 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2017/032714 |
Data | 2017-05-15 |
(87) | Numeris | WO 2017/200943 |
Data | 2017-11-23 |
(30) | Numeris | Data | Šalis |
201662337005 P | 2016-05-16 | US | |
201662414146 P | 2016-10-28 | US | |
201662420937 P | 2016-11-11 | US |
(72) |
BLACKWELL, William, US
SRIVASTAVA, Ved P., US
PAULIK, Mark A., US
YOUNG, Andrew, US
DOCK, Steven Thomas, US
HUNTER, III Robert Neil, US
|
(73) |
Intarcia Therapeutics, Inc,
One Marina Park Drive 13th Floor, Boston, MA 02210,
US
|
(54) | GLUCAGON-RECEPTOR SELECTIVE POLYPEPTIDES AND METHODS OF USE THEREOF |
GLUCAGON-RECEPTOR SELECTIVE POLYPEPTIDES AND METHODS OF USE THEREOF |